编辑推荐——一年RECAST注册研究中颈动脉再狭窄风险预测列线图的开发
基于2015年1月至2020年12月全国前瞻性多中心观察性RECAST注册研究,纳入354例接受颈动脉血管成形和支架植入术(CAS)且有至少一年随访的患者,构建预测CAS术后支架内再狭窄(ISR)≥70%的列线图。ISR≥70%发生率为7.6%(n=27),列线图纳入外周动脉疾病、前交通动脉缺如、糖尿病、女性、术前超声血管反应性异常五个独立危险因素,12和24个月一致性指数均为0.83。
要点
- RECAST注册研究中CAS术后ISR≥70%发生率为7.6%(27/354)。
- 列线图纳入外周动脉疾病、前交通动脉缺如、糖尿病、女性、术前超声血管反应性异常。
- 列线图12和24个月一致性指数均为0.83,低危组ISR≥70%为4.8%,高危组为56.2%(p<.001)。
核心结论
- 列线图及风险评估评分对ISR具有良好预测能力,可作为个体化风险评估的实用临床工具。
研究设计与样本
- 全国性观察性、前瞻性、多中心注册研究,于2015年1月至2020年12月开展。
- 纳入接受CAS的有症状或无症状重度颈动脉狭窄患者,随访至少一年,共354例纳入分析。
- 采用双功超声评估支架内再狭窄,比较非ISR组与ISR组的术前因素,采用Kaplan-Meier法和Cox回归进行变量筛选。
- 通过一致性指数和校准曲线构建并验证列线图,生成支架内再狭窄风险表用于风险分层。
主要发现
- ISR≥70%发生率为7.6%(n=27)。
- 外周动脉疾病(HR 3.18,95%CI 1.23-8.24,p=.017)、前交通动脉缺如(HR 3.38,95%CI 1.27-8.94,p=.016)、糖尿病(HR 3.34,95%CI 1.21-9.26,p=.020)、女性(HR 2.99,95%CI 1.04-8.60,p=.041)、术前超声血管反应性异常(HR 3.87,95%CI 1.43-10.50,p=.008)为ISR≥70%的独立危险因素,均纳入列线图。
- 12和24个月一致性指数均为0.83。
- 低危组随访期间ISR≥70%发生率为4.8%,高危组为56.2%(p<.001)。
关键数值与推荐
- 列线图纳入的独立危险因素及对应HR:外周动脉疾病HR 3.18(95%CI 1.23-8.24,p=.017)。
- 前交通动脉缺如HR 3.38(95%CI 1.27-8.94,p=.016)。
- 糖尿病HR 3.34(95%CI 1.21-9.26,p=.020)。
- 女性HR 2.99(95%CI 1.04-8.60,p=.041)。
- 术前超声血管反应性异常HR 3.87(95%CI 1.43-10.50,p=.008)。
临床怎么用
- 列线图及风险评估评分可用于CAS术后ISR的个体化风险评估。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The long term benefit of carotid angioplasty and stenting (CAS) can be reduced by recurrent stroke related to in stent re-stenosis (ISR). An individualised predictive tool is needed to identify ISR events. A nomogram for individual risk assessment of ISR ≥ 70% after CAS is proposed. METHODS: A national observational, prospective, multicentre registry was conducted between January 2015 and December 2020. Cohorts of patients with symptomatic or asymptomatic severe carotid stenosis who underwent CAS with a follow up of at least one year after CAS were included. Duplex ultrasound was used to assess in stent re-stenosis. Pre-operative factors were compared between the non-ISR and ISR groups. Kaplan-Meier and Cox regression were used for variable selection. The nomogram was formulated and validated by concordance indices and calibration curves. An in stent re-stenosis risk table was generated for risk stratification. RESULTS: A total of 354 patients were included in the analysis. The ISR rate of ≥ 70% was 7.6% (n = 27). Peripheral arterial disease (hazard ratio [HR] 3.18, 95% confidence interval [CI] 1.23 - 8.24, p = .017), anterior communicating artery absence (HR 3.38, 95% CI 1.27 - 8.94, p = .016), diabetes mellitus (HR 3.34, 95% CI 1.21 - 9.26, p = .020), female sex (HR 2.99, 95% CI 1.04 - 8.60, p = .041), and pre-procedure pathological ultrasound vasoreactivity (HR 3.87, 95% CI 1.43 -10.50, p = .008), as independent risk factors for ISR of ≥ 70%, were included in the nomogram. The concordance index at 12 and 24 months was 0.83. In low risk groups, ISR of ≥ 70% occurred in 4.8% of patients during follow up compared with 56.2% of patients in the high risk groups (p < .001). CONCLUSION: The nomogram and risk evaluation score have good predictive ability for ISR. They can be used as practical clinical tools for individualised risk assessment.
引用
- Zapata-Arriaza E, Aguilar Pérez M, Albóniga-Chindurza A, et al. Editor's Choice - Development of a Risk Prediction Nomogram for Carotid Re-Stenosis in the One Year RECAST Registry. Eur J Vasc Endovasc Surg. 2024. PMID: 38802040. doi:10.1016/j.ejvs.2024.05.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。